StemCyte International, Ltd. (TPEX:4178)

StemCyte International Statistics

Total Valuation

TPEX:4178 has a market cap or net worth of TWD 5.95 billion. The enterprise value is 4.11 billion.

Market Cap	5.95B
Enterprise Value	4.11B

Important Dates

The next estimated earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:4178 has 192.24 million shares outstanding. The number of shares has increased by 24.60% in one year.

Current Share Class	192.24M
Shares Outstanding	192.24M
Shares Change (YoY)	+24.60%
Shares Change (QoQ)	-4.01%
Owned by Insiders (%)	9.87%
Owned by Institutions (%)	9.44%
Float	159.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.45
PB Ratio	3.43
P/TBV Ratio	3.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-21.89
EV / Sales	10.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-48.13

Financial Position

The company has a current ratio of 10.81, with a Debt / Equity ratio of 0.13.

Current Ratio	10.81
Quick Ratio	9.07
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	-2.59
Interest Coverage	-17.09

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-8.21%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, TPEX:4178 has paid 672,000 in taxes.

Income Tax	672,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.69% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-25.69%
50-Day Moving Average	24.97
200-Day Moving Average	25.94
Relative Strength Index (RSI)	67.58
Average Volume (20 Days)	441,495

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4178 had revenue of TWD 385.12 million and -187.63 million in losses. Loss per share was -0.94.

Revenue	385.12M
Gross Profit	131.14M
Operating Income	-231.28M
Pretax Income	-186.96M
Net Income	-187.63M
EBITDA	-202.08M
EBIT	-231.28M
Loss Per Share	-0.94

Balance Sheet

The company has 2.06 billion in cash and 220.80 million in debt, giving a net cash position of 1.84 billion or 9.58 per share.

Cash & Cash Equivalents	2.06B
Total Debt	220.80M
Net Cash	1.84B
Net Cash Per Share	9.58
Equity (Book Value)	1.73B
Book Value Per Share	9.02
Working Capital	2.37B

Cash Flow

In the last 12 months, operating cash flow was -70.62 million and capital expenditures -14.74 million, giving a free cash flow of -85.36 million.

Operating Cash Flow	-70.62M
Capital Expenditures	-14.74M
Free Cash Flow	-85.36M
FCF Per Share	-0.44

Margins

Gross margin is 34.05%, with operating and profit margins of -60.05% and -48.72%.

Gross Margin	34.05%
Operating Margin	-60.05%
Pretax Margin	-48.55%
Profit Margin	-48.72%
EBITDA Margin	-52.47%
EBIT Margin	-60.05%
FCF Margin	n/a

Dividends & Yields

TPEX:4178 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.60%
Shareholder Yield	-24.60%
Earnings Yield	-3.15%
FCF Yield	-1.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:4178 has an Altman Z-Score of 2.77 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.77
Piotroski F-Score	2